drtimos.bsky.social
@drtimos.bsky.social
Signal or noise? > Booze Without the Burn? An Enzyme-Tinkering Startup Aims to
Make Spirits Smoother >> Comment below! #AI #mhealth #industry40 #healthtech #IoT
Booze Without the Burn? An Enzyme-Tinkering Startup Aims to Make Spirits Smoother
Voodoo Scientific has developed a process that, when applied to fiery hooch, results in a more sippable tipple.
dlvr.it
November 11, 2025 at 1:35 PM
LucidQuest Views >>> Lucid Diligence Brief: Galecto acquires Damora Therapeutics Comment below! #LucidQuest #PharmaCI
Lucid Diligence Brief: Galecto acquires Damora Therapeutics
Lucid Diligence Brief: Galecto acquires Damora Therapeutics Professional audiences only. Not investment research or advice. UK readers: for persons under […] The post Lucid Diligence Brief: Galecto acquires Damora Therapeutics appeared first on LucidQuest Ventures.
dlvr.it
November 11, 2025 at 1:34 PM
Signal or noise? > RNA-Based Gene Therapy Offers New Hope For ALS Patients -
Mirage News >> Comment below! #strategy #competitiveintelligence #marketing #pharmaceutical #biotech #pharma #healthcare #competitivemarketing
RNA-Based Gene Therapy Offers New Hope For ALS Patients - Mirage News
RNA-Based Gene Therapy Offers New Hope For ALS Patients  Mirage News
dlvr.it
November 11, 2025 at 1:30 PM
Signal or noise? > NHS providers reviewing stolen data published by cyber
criminals >> Comment below! #IoT #healthtech #industry40 #mhealth #AI
NHS providers reviewing stolen data published by cyber criminals
Pathology supplier Synnovis is contacting NHS organisations which had data stolen and published online following a major cyber attack.
dlvr.it
November 11, 2025 at 12:14 PM
Signal or noise? > Understanding the nuances of human-like intelligence >> Comment below! #mhealth #industry40 #AI #IoT #healthtech
Understanding the nuances of human-like intelligence
Associate Professor Phillip Isola studies the ways in which intelligent machines “think,” in an effort to safely integrate AI into human society.
dlvr.it
November 11, 2025 at 10:26 AM
How to win in #Oncology and #Hematology in 2025

📥 Get a FREE #LucidQuest Report http://dlvr.it/TPBy8w

🚀 Oncp/hema drug development is evolving fast. AI-driven Dx, novel MoAs & outcomes-based pricing are reshaping the landscape.

🏆 Who’s leading? AbbVie, Amgen, AZ, BMS, J&J & Novartis.
How to win in Oncology and Hematology in 2025
Fill in this form and get your report right now! Gain access to the onco / hem indications and the most popular mechanisms of action the leading BioPharma companies have been targeting and pursuing as at Q1 2025 (and beyond). In this concise report, we share the findings of the analysis of the portfolios and pipelines of 15 oncology and hematology companies and present a space overview and individual company profiles. Contact us at info@lqventures.com for more information or any other feedback. LucidQuest is committed to empowering its BioPharma and Life Sciences Investment industry stakeholders with up-to-date knowledge and analysis. Stay tuned for more free reports coming up in 2025 covering Cell and Gene Therapy, Multiple Sclerosis, Digital Health, Venture Capital investment in Pharma, and other spaces. The LucidQuest team
dlvr.it
November 11, 2025 at 10:19 AM
LucidQuest Views >>> Obesity Video Recap—November 11, 2025 Comment below! #LucidQuest #PharmaCI
Obesity Video Recap—November 11, 2025
This biweekly obesity video recap reviews major moves shaping the obesity and metabolic landscape—from strategic deals and late-stage data to […] The post Obesity Video Recap—November 11, 2025 appeared first on LucidQuest Ventures.
dlvr.it
November 11, 2025 at 10:03 AM
LucidQuest Views >>> Endocrinology Today—November 11, 2025 Comment below! #LucidQuest #PharmaCI
Endocrinology Today—November 11, 2025
This week in endocrinology: fresh clinical readouts, market-moving industry moves, and updates from top biopharma players. In Today’s Newsletter Dive […] The post Endocrinology Today—November 11, 2025 appeared first on LucidQuest Ventures.
dlvr.it
November 11, 2025 at 9:45 AM
💉 Vaccines & Infectious Diseases 🦠
#LucidQuest equips BioPharma & investors with real-time insights to outpace the curve.
📩 info@lqventures.com or http://dlvr.it/TPBtT0
#Vaccines #InfectiousDiseases #BioPharma #DueDiligence #LifeScienceStrategy
Vaccines & Infectious Diseases Research - LucidQuest Ventures
Strategic Insights and Consulting to Succeed in Vaccines
dlvr.it
November 11, 2025 at 8:58 AM
LucidQuest Views >>> Lucid Diligence Brief: Iambic raises $100M+ for AI drug discovery Comment below! #LucidQuest #PharmaCI
Lucid Diligence Brief: Iambic raises $100M+ for AI drug discovery
Lucid Diligence Brief: Iambic raises $100M+ for AI drug discovery Professional audiences only. Not investment research or advice. UK readers: […] The post Lucid Diligence Brief: Iambic raises $100M+ for AI drug discovery appeared first on LucidQuest Ventures.
dlvr.it
November 11, 2025 at 8:33 AM
Signal or noise? > Essity Collaborates with Accenture and Microsoft to
Accelerate Adoption of AI Agents to Drive Productivity and
Growth >> Comment below! #healthtech #industry40 #AI #mhealth #IoT
Essity Collaborates with Accenture and Microsoft to Accelerate Adoption of AI Agents to Drive Productivity and Growth
NEW YORK & STOCKHOLM–(BUSINESS WIRE)–Essity (STO: ESSITY-B) has selected Accenture (NYSE: ACN) and Microsoft to help the global hygiene and health company accelerate the use of AI agents to unlock value and drive efficiencies and growth through improved business agility. As part of the multi-year collaboration, the companies will work together at Essity’s AI Centre …
dlvr.it
November 11, 2025 at 8:11 AM
Signal or noise? > New Research On Gene Editing Therapy May Cut Cholesterol,
Triglycerides By Half - NDTV >> Comment below! #strategy #competitiveintelligence #marketing #competitivemarketing #healthcare #pharma #biotech #pharmaceutical
New Research On Gene Editing Therapy May Cut Cholesterol, Triglycerides By Half - NDTV
New Research On Gene Editing Therapy May Cut Cholesterol, Triglycerides By Half  NDTV
dlvr.it
November 11, 2025 at 7:29 AM
Signal or noise? > Decoding uniQure NV (QURE): A Strategic SWOT Insight -
GuruFocus >> Comment below! #strategy #competitiveintelligence #marketing #healthcare #pharmaceutical #biotech #pharma #competitivemarketing
Decoding uniQure NV (QURE): A Strategic SWOT Insight - GuruFocus
Decoding uniQure NV (QURE): A Strategic SWOT Insight  GuruFocus
dlvr.it
November 11, 2025 at 5:59 AM
Signal or noise? > Tungsten Automation Launches Power PDF 2025.3: Bringing
Cloud Editing, New Collaboration Options, Deeper AI Integration,
and ARM Support to the Enterprise Desktop >> Comment below! #industry40 #mhealth #AI #healthtech #IoT
Tungsten Automation Launches Power PDF 2025.3: Bringing Cloud Editing, New Collaboration Options, Deeper AI Integration, and ARM Support to the Enterprise Desktop
The latest release of Tungsten Automation’s flagship PDF solution introduces browser-based editing, Microsoft 365 collaboration, and native Windows-on-ARM support. It also marks the beginning of a more flexible SaaS licensing model designed to meet growing enterprise demand for secure, AI-enabled document workflows. IRVINE, Calif.–(BUSINESS WIRE)–Tungsten Automation today announced the launch of Power PDF 2025.3 for …
dlvr.it
November 11, 2025 at 5:56 AM
Signal or noise? > A new project aims to predict how quickly AI will
progress >> Comment below! #strategy #competitiveintelligence #marketing #healthcare #productmarketing #pharmaceutical #biotech #pharma
A new project aims to predict how quickly AI will progress
Superforecasters weigh in on the subject
dlvr.it
November 11, 2025 at 3:35 AM